Medication info
Dimantin Tablet 10mg (Memantine Hydrochloride)

Dimantin Tablet 10mg (Memantine Hydrochloride)

Prescription medicationTabletOral
Ingredient · strength
Memantine Hydrochloride›10mg / 1 tablet
Manufacturer / importer
Hyundai Pharmaceutical Co., Ltd.
Appearance
White, rectangular film-coated tablet
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 201405370 · Approved 2014.11.18 · Insurance code 642003420

Summary

Main use
Treatment of moderate to severe Alzheimer's disease
Who takes it
Adults
Adult dose
Treatment must be initiated by a physician experienced in the diagnosis and treatment of Alzheimer’s dementia, and only if a caregiver is available to regularly check that the patient takes the medicine. Diagnosis should be made according to currently accepted guidelines. The clinical benefit of this medicine and the patient’s tolerability of treatment should be reassessed regularly. This medicine is administered orally once daily, at the same time each day. If necessary, this medicine may be administered twice daily. This medicine may be taken with or without food. 1. Adults Dose escalation: The maximum daily dose is 20mg. To minimize the risk of adverse reactions, increase the dose by 5mg per week over the first 3 weeks as follows to reach the maintenance dose. Week 1 (days 1–7): Administer 5mg daily for 7 days. Week 2 (days 8–14): Administer 10mg daily for 7 days. Week 3 (days 15–21): Administer 15mg daily for 7 days. From week 4 onward: Administer 20mg daily. Maintenance dose: The recommended maintenance dose is 20mg daily. 2. Elderly Based on clinical data, the recommended dose for elderly patients aged 65 years or older is 20mg daily. 3. Patients with renal impairment No dose adjustment is necessary in patients with mild renal impairment (creatinine clearance: 50-80 mL/min). In patients with moderate renal impairment (creatinine clearance 30-49 mL/min), reduce the daily dose to 10mg. If well tolerated, the dose may be increased to 20mg daily according to the standard dose escalation schedule after at least 7 days of treatment. In patients with severe renal impairment (creatinine clearance 5-29mL/min), reduce the daily dose to 10mg. 4. Patients with hepatic impairment No dose adjustment is necessary in patients with mild or moderate hepatic impairment (Child-Pugh A, Child-Pugh B). Since there are no data on the use of memantine in patients with severe hepatic impairment, it is preferable not to administer this medicine.

Ingredients

Manufacturer
Hyundai Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of moderate to severe Alzheimer's disease

View approved original text

This medication is used for the treatment of moderate to severe Alzheimer's disease. It helps improve the patient's cognitive decline and daily living abilities.

How to take

Adult dose

Treatment must be initiated by a physician experienced in the diagnosis and treatment of Alzheimer’s dementia, and only if a caregiver is available to regularly check that the patient takes the medicine. Diagnosis should be made according to currently accepted guidelines. The clinical benefit of this medicine and the patient’s tolerability of treatment should be reassessed regularly. This medicine is administered orally once daily, at the same time each day. If necessary, this medicine may be administered twice daily. This medicine may be taken with or without food. 1. Adults Dose escalation: The maximum daily dose is 20mg. To minimize the risk of adverse reactions, increase the dose by 5mg per week over the first 3 weeks as follows to reach the maintenance dose. Week 1 (days 1–7): Administer 5mg daily for 7 days. Week 2 (days 8–14): Administer 10mg daily for 7 days. Week 3 (days 15–21): Administer 15mg daily for 7 days. From week 4 onward: Administer 20mg daily. Maintenance dose: The recommended maintenance dose is 20mg daily. 2. Elderly Based on clinical data, the recommended dose for elderly patients aged 65 years or older is 20mg daily. 3. Patients with renal impairment No dose adjustment is necessary in patients with mild renal impairment (creatinine clearance: 50-80 mL/min). In patients with moderate renal impairment (creatinine clearance 30-49 mL/min), reduce the daily dose to 10mg. If well tolerated, the dose may be increased to 20mg daily according to the standard dose escalation schedule after at least 7 days of treatment. In patients with severe renal impairment (creatinine clearance 5-29mL/min), reduce the daily dose to 10mg. 4. Patients with hepatic impairment No dose adjustment is necessary in patients with mild or moderate hepatic impairment (Child-Pugh A, Child-Pugh B). Since there are no data on the use of memantine in patients with severe hepatic impairment, it is preferable not to administer this medicine.

Precautions

This medication should not be used by patients allergic to any of its components. It should also not be administered to patients with severely impaired liver function or significantly poor kidney function. Additionally, as this medication contains lactose, patients with genetic conditions that prevent lactose digestion should not take it. Patients with epilepsy or those who have previously experienced seizures or are at high risk for the development of epilepsy should use this medication with caution. Furthermore, taking this medication with other drugs that act on NMDA receptors may exacerbate side effects, so it is advisable not to use them together. Patients who have factors that alter urinary acidity (pH) need careful monitoring when taking this medication. The safety of this medication has not been sufficiently established in patients with heart disease or uncontrolled hypertension, so it should be administered cautiously. When taking this medication, symptoms such as dizziness, headache, constipation, drowsiness, and hypertension may occur, and any unusual symptoms should be discussed with a doctor. This medication may interact with other drugs, so patients should inform their doctor or pharmacist if they are taking any other medications. Special caution is needed when taken with NMDA antagonists, antipsychotics, antihypertensives, and anticoagulants. Pregnant women or women of childbearing potential should consult a doctor before taking this medication, as it may affect the fetus. Nursing women are advised to discontinue breastfeeding because this medication may pass into breast milk. The safety and efficacy of this medication in children or adolescents under 18 years of age have not been established. In the event of overdose, symptoms such as confusion, drowsiness, dizziness, hallucinations, vomiting, and diarrhea may occur, and immediate medical attention should be sought. This medication may affect the patient's mental state, so caution is warranted while driving or operating machinery. Lastly, this medication should be kept out of reach of children and should not be transferred to another container.

Side effects

  • Dizziness
  • headache
  • constipation
  • drowsiness
  • hypertension
  • fungal infection
  • drug hypersensitivity reaction
  • confusion
  • hallucinations
  • psychotic reactions
Show 25 more
  • balance disorders
  • gait abnormalities
  • seizures
  • heart failure
  • venous thrombosis
  • thromboembolism
  • shortness of breath
  • vomiting
  • pancreatitis
  • elevated liver function test results
  • hepatitis
  • fatigue
  • nonspecific fatigue
  • weakness
  • diarrhea
  • agitation
  • aggression
  • stupor
  • unconsciousness
  • restlessness
  • psychosis
  • visual disturbances
  • convulsions
  • coma
  • double vision

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent air ingress, at a temperature between 1 and 30 degrees Celsius. This storage method helps maintain the medication's effectiveness and prevents degradation.

Appearance and packaging

Appearance

White, rectangular film-coated tablet

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.